Blog
Investigational drugs reduce risk of death from Ebola virus disease
The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo (DRC). » Read more Source: Medical Xpress
New weapon in fight against lethal fungi
Researchers have gained insights into how nanoparticles could develop a biosensor to prevent deadly diseases contracted on medical equipment, such as catheters. » Read more Source: Science Daily
Drug can extend survival rates for heart failure patients
Blood pressure medication can prevent fluid retention and muscle wasting in heart failure. » Read more Source: Science Daily
Scientists prove low cost arthritis drug can effectively treat blood cancer sufferers
A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study has shown. » Read more Source: Science Daily
Respiratory diseases linked with high blood pressure in lungs
Pulmonary hypertension is a type of high blood pressure that affects the lungs of both animals and people. When tiny vessels in the lungs become narrowed or blocked, it becomes harder for blood to flow through and can cause the heart to weaken or fail. » Read more Source: Science Daily
One third of patients with severe asthma are taking harmful doses of oral steroids
A third of patients with severe asthma are taking harmful doses of oral steroids, according to a study of several thousand people in The Netherlands. » Read more Source: Science Daily
New treatment may reverse celiac disease
A phase 2 clinical trial using a new technology show it is possible to induce immune tolerance to gluten in individuals with celiac disease. After treatment with the technology, the patients were able to eat gluten with a substantial reduction in inflammation. » Read more Source: Science Daily
Type 2 diabetes remission possible with ‘achievable’ weight loss
People who achieve weight loss of 10% or more in the first five years following diagnosis with type 2 diabetes have the greatest chance of seeing their disease go into remission, according to a new study. » Read more Source: Science Daily
Vitamin D and fish oil show promise in prevention of cancer death and heart attacks
The VITamin D and OmegA-3 Trial (VITAL) is the largest and most recent to test whether vitamin D or fish oil can effectively prevent cancer or cardiovascular disease. Results to date have been mixed but show promise for some outcomes, now confirmed by updated pooled (meta) analyses. » Read more Source: Science Daily
Eating more plant-based protein lowers mortality risk
Increased plant protein intake lowers the risk for overall and cardiovascular mortality, according to a study published in JAMA Internal Medicine. » Read more Source: Healio